lymphokine-activated killer
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
11
Involvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2 induced lymphokine activated killer generation
6
Lymphocytes expressing type 3 complement receptors proliferate in response to interleukin 2 and are the precursors of lymphokine activated killer cells
9
Celecoxib increases lung cancer cell lysis by lymphokine- activated killer cells via upregulation of ICAM-1
15
Natural Killer Cell Immunodeficiency in Siblings: Defective Killing in the Absence of Natural Killer Cytotoxic Factor Activity in Natural Killer and Lymphokine-Activated Killer Cytotoxicities
10
Antiviral effect of lymphokine-activated killer cells: characterization of effector cells mediating prophylaxis.
7
Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma
13
Characterization of cytotoxic cells from reovirus-infected SCID mice: activated cells express natural killer- and lymphokine-activated killer-like activity but fail to clear infection.
5
Interleukin-2-inducible natural immune (lymphokine-activated killer cell) responses as a functional correlate of progression to AIDS.
7
Immune cell therapy for hepatocellular carcinoma
11
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014
23
The Natural Killer Cell: A Historical Perspective and the Use of Supplements to Enhance NKC Activity
32
Role of human natural killer cells in health and disease.
9
Killing of intracellular Leishmania donovani by lymphokine stimulated human mononuclear phagocytes Evidence that interferon gamma is the activating lymphokine
6
Dendritic Polymers for Theranostics
18
Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells
15
Case Report Aggressive natural killer cell leukemia mimicking interstitial lung diseases with the activation of the mitogen-activated protein kinase pathway
7
Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection.
11
Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells
16
Pulmonary manifestations in Behçet disease: impaired natural killer cells activity
8